Windows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallCrashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minuteEverus Construction Group (NYSE: ECG) has reported rapid growth, stronger margins and a much larger backlog—but those operating results alone do not show that its shares are affordable. The company’s 2025 results and first-half 2026 performance make a credible growth case. A valuation judgment still requires a dated share price and comparison with earnings and relevant peers, which are not established here.
What Everus Construction Group does
Everus is a U.S. specialty contractor that became an independent public company in 2024 after separating from MDU Resources. It reports two operating segments: Electrical & Mechanical (E&M) and Transmission & Distribution (T&D). Because 2025 was its first full year as an independent public company, comparisons with earlier periods include the effects of its transition; the company’s annual report says 2025 results absorbed incremental stand-alone costs.
As an Amazon Associate I earn from qualifying purchases.
E&M provides electrical and communications infrastructure, fire suppression, mechanical piping and related services. T&D builds overhead and underground electrical, gas and communications infrastructure, and includes transmission-line construction equipment manufacturing and distribution. Its end markets include commercial, industrial, institutional, renewable-energy, service, transportation and utility work. Everus’s company information describes its business; its SEC filings provide reporting detail.
What the reported results say about growth
Full-year 2025
Everus reported $3.75 billion in revenue for 2025, up 31.5% year over year, and net income of $201.8 million, up 40.7%. Diluted earnings per share were $3.95, a 40.6% increase. The company also reported $319.8 million in EBITDA, up 37.7%; EBITDA is a non-GAAP measure, so it should be read alongside GAAP earnings and cash flow, not as a replacement for either.
#1 Best Overall
- Comes with secure packaging
- Easy to read text
- It can be a gift option
Year-end backlog was $3.23 billion as of December 31, 2025, 16.1% above December 31, 2024. Backlog represents contracted work to be performed; it is not equivalent to revenue, profit or guaranteed future cash flow. These figures are from Everus’s 2025 results release and annual report filings.
First half and second quarter of 2026
In the second quarter of 2026, revenue reached $1.23 billion, up 33.7% year over year, and net income was $83.9 million, up 58.9%. Quarterly EBITDA was $128.6 million, up 52.7%, while EBITDA margin rose to 10.4% from 9.1% a year earlier. Gross margin increased to 14.9% from 13.0%.
Rank #2
- Ideal for Gifting
- Ideal for a bookworm
- Comes with Proper Binding
For the six months ended June 30, 2026, Everus reported $167.0 million of free cash flow. The same period included $147.6 million in net cash outflows related to the SE&M acquisition, so the cash-generation figure should be considered alongside acquisition spending. Net leverage was 0.3x at June 30, 2026. The company’s Q2 2026 results release reports these figures.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Growth is concentrated in E&M, not evenly spread
Q2 segment results show different growth rates. E&M revenue rose 41.6% year over year, or 36.9% organically excluding SE&M. Company commentary pointed to commercial and industrial work, particularly continued data-center growth. T&D revenue rose 7.1%, led by utility workloads in transmission and distribution.
The backlog mix reinforces that distinction. At June 30, 2026, E&M backlog was $4.16 billion, up 62.1% year over year. T&D backlog was $388.4 million, down from $410.1 million a year earlier. Total backlog stood at $4.55 billion, 52.8% higher than on June 30, 2025. The increase is therefore heavily weighted toward E&M, rather than evidence of equal acceleration across both segments.
That mix matters to an investor assessing resilience. E&M’s demand includes data centers, hospitality and high-tech work, while T&D is tied to utility and infrastructure activity. The available figures establish growth and backlog levels, but do not by themselves establish how diversified revenue is among customers or end markets. Everus’s SEC filings are the place to examine those exposures.
Margins and cash flow: promising, but not proof of durable returns
The year-over-year increases in Q2 gross and EBITDA margins are positive evidence of improved profitability in that quarter. Everus attributed gross-profit growth to higher revenue and margin improvement associated with increased workloads, project execution and timing. Those factors are relevant caveats: project mix, timing and execution can change, and one strong quarter does not establish a lasting margin step-up.
Quick wins for a faster PC:
Repair Windows errors before they cause bigger problemsFix Now →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Likewise, rising net income and EPS demonstrate accounting profit growth, not necessarily high-quality long-term returns on capital. The figures cited here do not establish a consistent multiyear return on invested capital, return on equity, shareholder total return or durable cash conversion. Those claims require a defined return measure and a comparable series over time. Free cash flow should also be interpreted with capital expenditures and acquisition outlays in view.
Best Value
Management outlook is guidance, not a realized result
On August 4, 2026, Everus raised its full-year 2026 outlook to revenue of $4.5 billion–$4.7 billion and EBITDA of $410 million–$425 million. These are management forecasts, not completed results. In its Q2 release, CEO Jeffrey S. Thiede described “another quarter of record revenues, margin expansion and robust backlog growth.” That is management’s characterization of the quarter, not independent evidence that the trend will persist.
The company’s Q2 filing cautions that interim results are not necessarily indicative of the full year or future periods. Guidance can be affected by project execution, labor availability and costs, workload timing, end-market demand and acquisition integration.
Why the word “affordable” is not yet supported
Strong growth does not establish a low share price or attractive valuation. The available figures do not provide a dated ECG share price, market capitalization, price-to-earnings ratio, enterprise-value-to-EBITDA multiple or comparison with appropriate specialty-contractor peers. Without those inputs, calling the shares “affordable” would go beyond the evidence.
A useful valuation assessment needs a market quote dated to the analysis and a clearly identified earnings period or estimate. It should compare ECG with suitable peers while accounting for acquisition effects, cyclicality, variable project margins and the fact that backlog must still convert into completed work and cash. No single growth rate or backlog figure can substitute for that comparison.
Risks to weigh against the growth case
- Segment and end-market mix: E&M now represents most backlog, and its growth is linked in part to data centers and other commercial and industrial activity. T&D backlog was lower year over year at June 30, 2026.
- Project execution and labor: Project timing, execution, labor availability and labor costs can affect revenue and margins.
- Acquisitions: SE&M affected first-half cash flows. Everus announced an agreement to acquire Epsilon Industries on July 31, 2026; the Q2 release described the transaction as pending and expected to close, not completed.
- Backlog conversion: Contracted work is not guaranteed revenue, profit or cash flow, and schedules or economics can change.
- Forecast uncertainty: Full-year guidance is forward-looking, and interim results are not necessarily indicative of later periods.
How to judge ECG’s investment case
For a decision about whether ECG offers attractive growth at a reasonable price, evaluate the company across several distinct questions rather than treating growth as a valuation answer:
Quick Recap
- What valuation do the shares imply against current or estimated earnings and EBITDA, and how does that compare with appropriate specialty-contractor peers?
- How much growth is organic versus acquisition-related?
- Are E&M and T&D growth, backlog and end-market exposures balanced or increasingly concentrated?
- How have margins behaved across multiple periods, rather than only in the latest quarter?
- How well do earnings convert to cash after capital expenditures, acquisition outlays and other investment needs?
- How much backlog converts into revenue and profit, and over what time frame?
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
